Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
China Petroleum & Chemical Corp ADR is an oil & gas integrated business based in the US. China Petroleum-and-Chemical Corp ADR shares (SNP) are listed on the NYSE and all prices are listed in US Dollars. China Petroleum-and-Chemical Corp ADR employs 385,691 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $45.14 |
|---|---|
| 52-week range | $36.93 - $50.06 |
| 50-day moving average | $48.77 |
| 200-day moving average | $49.23 |
| Wall St. target price | $56.75 |
| PE ratio | 4.8226 |
| Dividend yield | $0.47 (16.41%) |
| Earnings per share (TTM) | $9.36 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $45.14 from 2022-07-01
| 1 week (2022-06-28) | -1.48% |
|---|---|
| 1 month (2022-06-03) | -16.07% |
| 3 months (2022-04-05) | -11.97% |
| 6 months (2022-01-05) | -7.37% |
| 1 year (2021-07-02) | -11.89% |
|---|---|
| 2 years (2020-07-02) | 4.56% |
| 3 years (2019-07-05) | 67.25 |
| 5 years (2017-07-05) | 78.27 |
Valuing China Petroleum-and-Chemical Corp ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of China Petroleum-and-Chemical Corp ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
China Petroleum-and-Chemical Corp ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, China Petroleum-and-Chemical Corp ADR shares trade at around 5x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
China Petroleum-and-Chemical Corp ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.4497. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into China Petroleum-and-Chemical Corp ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
China Petroleum-and-Chemical Corp ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $224.7 billion.
The EBITDA is a measure of a China Petroleum-and-Chemical Corp ADR's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2,934.3 billion |
|---|---|
| Operating margin TTM | 4.09% |
| Gross profit TTM | $519.8 billion |
| Return on assets TTM | 3.93% |
| Return on equity TTM | 9.6% |
| Profit margin | 2.58% |
| Book value | $655.30 |
| Market capitalisation | $70.2 billion |
TTM: trailing 12 months
Dividend payout ratio: 102.63% of net profits
Recently China Petroleum-and-Chemical Corp ADR has paid out, on average, around 102.63% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 16.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), China Petroleum-and-Chemical Corp ADR shareholders could enjoy a 16.41% return on their shares, in the form of dividend payments. In China Petroleum-and-Chemical Corp ADR's case, that would currently equate to about $0.47 per share.
China Petroleum-and-Chemical Corp ADR's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
China Petroleum-and-Chemical Corp ADR's most recent dividend payout was on 29 June 2022. The latest dividend was paid out to all shareholders who bought their shares by 7 June 2022 (the "ex-dividend date").
China Petroleum-and-Chemical Corp ADR's shares were split on a 13:10 basis on 1 July 2013. So if you had owned 10 shares the day before before the split, the next day you'd have owned 13 shares. This wouldn't directly have changed the overall worth of your China Petroleum-and-Chemical Corp ADR shares – just the quantity. However, indirectly, the new 23.1% lower share price could have impacted the market appetite for China Petroleum-and-Chemical Corp ADR shares which in turn could have impacted China Petroleum-and-Chemical Corp ADR's share price.
Over the last 12 months, China Petroleum-and-Chemical Corp ADR's shares have ranged in value from as little as $36.9297 up to $50.0552. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while China Petroleum-and-Chemical Corp ADR's is 0.9313. This would suggest that China Petroleum-and-Chemical Corp ADR's shares are less volatile than average (for this exchange).
China Petroleum & Chemical Corporation, an energy and chemical company, engages in the oil and gas and chemical operations in Mainland China, Singapore, and internationally. It operates through five segments: Exploration and Production, Refining, Marketing and Distribution, Chemicals, and Corporate and Others. The company explores and develops oil fields; produces crude oil and natural gas; processes and purifies crude oil; and manufactures and sells petroleum products. It also owns and operates oil depots and service stations; and distributes and sells refined petroleum products, including gasoline and diesel through wholesale and retail sales networks. In addition, the company manufactures and sells petrochemical and derivative petrochemical products; and other chemical products, such as basic organic chemicals, synthetic resins, synthetic fiber monomers and polymers, synthetic fibers, synthetic rubber, and chemical fertilizers. Further, it is involved in the exploration, production, and sale of petroleum and natural gas; production, storage, and sale of petrochemical and coal chemical products; import and export of petroleum products, natural gas, petrochemical, and chemical products; production and sale of catalyst products, lubricant base oil, polyester chips and fibers, plastics, and intermediate petrochemical products; research, development, production, and sale of ethylene and downstream byproducts; provision of geophysical exploration, drilling, survey, logging, downhole operational services, and construction services, as well as crude oil jetty services and natural gas pipeline transmission services; manufacturing production equipment; and coal chemical industry investment management activities. The company was incorporated in 2000 and is headquartered in Beijing, China.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.